Questioning the methodologic superiority of 'placebo' over 'active' controlled trials.
A resilient issue in research ethics is whether and when a placebo-controlled trial (PCT) is justified if it deprives research subjects of a recognized treatment. The clinicians' moral duty to provide the best available care seems to require the use of 'active' controlled trials (ACTs...
| Hovedforfatter: | |
|---|---|
| Format: | Journal article |
| Sprog: | English |
| Udgivet: |
2009
|